Humana Inc. ($HUM) Stock Forecast: Up 7.9% Today

What is Humana Inc.?

Humana (NYSE: HUM) is a leading healthcare company operating in the Medicare Advantage market, prioritizing profitability and stability amidst increasing medical costs. The stock showed strong bullish movement recently.

Why is Humana Inc. going up?

HUM stock is up 7.9% on Apr 30, 2026 13:50

• The bullish movement in Humana's stock is linked to its robust first-quarter earnings performance, surpassing expectations despite a year-over-year profit decrease.
• Investor optimism is fueled by expectations of a substantial 25% growth in Medicare Advantage membership for the year, indicating strong member retention and revenue potential.
• Despite concerns about margin pressure from escalating medical costs surpassing funding, Humana's strategic focus on profit recovery and cost efficiencies is well-received by investors, propelling the stock upwards.
• Humana's commitment to reaching a 3% Medicare Advantage margin by 2028, even if necessitating benefit reductions or plan exits, exhibits a clear strategy for enhancing profitability and long-term stability, bolstering investor confidence in the stock.

HUM Price Chart

HUM Technical Analysis

HUM News

UnitedHealth Group Incorporated Stock (US91324P1021): Q4 and Full Year 2024 Results Scheduled for January 16, 2025

UnitedHealth Group will release its Q4 and full year 2024 financial results on January 16, 2025, before the market opens, followed by a teleconference at 8:45 a.m. ET. The company operates across various healthcare segments, including insurance and health services. This announcement is significant for investors following the US healthcare sector and UnitedHealth Group's performance.

https://www.ad-hoc-news.de/boerse/news/ueberblick/unitedhealth-group-incorporated-stock-us91324p1021-q4-and-full-year/69263755

Flowserve Corporation Reveals Climb In Q1 Income

Flowserve Corporation (FLS) announced an increase in its first-quarter earnings, with net income rising to $81.68 million ($0.64 per share) from $73.90 million ($0.56 per share) the previous year. Despite the earnings growth, the company's revenue for the quarter declined by 7.0% to $1.06 billion. Flowserve also provided guidance for the full year, projecting EPS between $4.00 and $4.20 and revenue growth between 3% and 6%.

https://www.rttnews.com/3644927/flowserve-corporation-reveals-climb-in-q1-income.aspx?type=ern

Humana on track for 25% growth in Medicare Advantage membership

Humana anticipates a significant 25% increase in Medicare Advantage membership this year, primarily due to strong member retention. Despite a slight dip in net income, the company exceeded Wall Street's revenue expectations and is focused on improving its MA star ratings and expanding its CenterWell Senior Primary Care footprint. These efforts are part of a broader strategy to enhance profitability and stability in the MA market, despite rising medical costs.

https://www.healthcarefinancenews.com/news/humana-track-25-growth-medicare-advantage-membership

What's Going On With Humana Stock Wednesday? - Humana (NYSE:HUM)

Humana (NYSE: HUM) stock rose after reporting first-quarter earnings that beat expectations despite a year-over-year profit decline, driven by higher sales and membership growth. The company's management highlighted improvements in cost ratios but warned of ongoing margin pressure due to rising medical costs outpacing funding. Humana affirmed its fiscal 2026 adjusted earnings per share and expects continued growth in Medicare Advantage membership.

https://www.benzinga.com/markets/earnings/26/04/52137822/humana-bets-on-cms-rate-relief-but-admits-cost-pressures-persist

Profit recovery is ‘priority No. 1,’ Humana promises

Humana's CEO Jim Rechtin has stated that returning to a 3% Medicare Advantage margin in 2028 is the company's top priority, despite investor concerns about increased membership. While the company saw Q1 revenue and earnings in line with expectations and slightly better than expected medical and pharmacy cost trends, Wall Street remains skeptical. Rechtin emphasized that profit recovery for 2027 and 2028 will guide their strategy, even if it means benefit cuts or plan exits, relegating member stability to a "distant third" priority.

https://www.healthcaredive.com/news/humana-promises-margin-recovery-q1-2026-hum-medicare-advantage/818743/

Trending Today

Crude Oil ($CRUDE) Commodity Forecast: Down 5.1% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 5.1% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

Shoals Technologies Group Inc. ($SHLS) Stock Forecast: Down 10.3% Today

DaVita Inc. ($DVA) Stock Forecast: Up 5.1% Today

Skyworks Solutions Inc. ($SWKS) Stock Forecast: Up 5.2% Today

Coty Inc. Class A ($COTY) Stock Forecast: Up 5.6% Today

Rockwell Automation Inc. ($ROK) Stock Forecast: Up 8.9% Today

Intel Corporation ($INTC) Stock Forecast: Up 11.7% Today

Quidelortho Corpoation ($QDEL) Stock Forecast: Down 5.5% Today

Humana Inc. Price History

26.01.2026 - HUM Stock was up 5.5%

• The positive partnership between Humana and data automation startup Veda to enhance provider directories has led to a bullish movement in Humana's stock today, aiming to address inaccuracies in provider information and improve patient care access.
• Despite a significant year-to-date stock price decline, analysts suggest that Humana’s current undervaluation may attract investors seeking discounted opportunities.
• Analysts point out three key factors that could drive Humana's potential upside: strong long-term revenue growth, economies of scale, and a strategic focus on Medicare Advantage plans, indicating consistent growth and capital efficiency.
• The upcoming resolution of Medicare Advantage payment rates may influence investor sentiment towards managed-care stocks like Humana, with a final announcement expected by April 6, following the after-hours slip in UnitedHealth (UNH) stock.

07.03.2026 - HUM Stock was up 11.4%

• Humana's bullish movement can be attributed to the decision by the Trump administration to significantly raise Medicare insurer payments, benefiting companies like Humana that offer Medicare Advantage plans.
• The finalized 2.48% rate increase for 2027 Medicare Advantage and Part D payments by CMS provided clarity and support for Humana's profitability in the Medicare Advantage sector.
• Investor attention towards healthcare companies like Humana has increased due to brighter prospects in the managed care industry following the rise in Medicare Advantage rates for 2027.
• The market movement reflects a positive sentiment towards health insurance stocks, with companies like Humana expected to benefit from the revised Medicare payment plans and increased profitability in the sector.

11.01.2026 - HUM Stock was down 7.6%

• Humana's wider fourth-quarter loss was primarily driven by increased medical costs and decreased quality ratings for its Medicare plans. This led to a less optimistic earnings outlook for 2026.
• Despite exceeding revenue forecasts, concerns about lower quality ratings on its Medicare Advantage plans and the potential loss of government bonus payments affected investor confidence, resulting in a bearish movement for Humana's stock.
• The contrast between the strong revenue performance and the negative earnings forecast for 2026 likely influenced the downward trend in Humana's stock, reflecting a more pessimistic market sentiment towards the company.

11.01.2026 - HUM Stock was down 5.7%

• Humana's ambitious growth strategy to become the largest Medicare Advantage insurer by 2026, despite facing challenges such as elevated medical spending and investor concerns, might have raised doubts among investors, leading to the bearish market movement.
• The wider fourth-quarter loss reported by Humana, driven by surging medical costs and downgraded quality ratings for its Medicare plans, likely contributed to the negative investor sentiment and the stock's decline.
• Despite exceeding revenue forecasts and narrowing its loss compared to the previous year, Humana's disappointing 2026 earnings guidance, falling significantly below analyst expectations, could have triggered the bearish market movement as investors reevaluated the company's future prospects.
• The market's reaction to Humana's performance highlights the importance of managing cost pressures, maintaining plan quality, and meeting investor expectations in the highly competitive healthcare insurance industry.

07.03.2026 - HUM Stock was up 8.8%

• Humana's stock surged 11% after a 2.48% rate increase for Medicare Advantage plans in 2027 was finalized by the Centers for Medicare and Medicaid Services (CMS), exceeding initial proposals. This favorable rate update removes uncertainty for investors and provides breathing room for the company to work towards its earnings targets.
• The decision to boost Medicare Advantage payments for 2027 not only positively impacted Humana but also other major healthcare companies like UnitedHealth and CVS Health, leading to a sector-wide rally.
• Despite facing challenges like margin pressure and integrating new members, Humana is well-positioned to benefit from the increased payments, which are projected to funnel over $13 billion in additional payments, providing a significant boost to the company's revenue outlook.
• This market movement reflects investor confidence in Humana's ability to navigate industry challenges and capitalize on the favorable regulatory environment to drive growth and profitability in the coming years.

24.01.2026 - HUM Stock was down 5.1%

• Humana's weaker Q4 2025 results and soft 2026 GAAP EPS outlook have led to a bearish market movement as investors digest the short-term earnings pressures and regulatory uncertainties.
• The company's decision to affirm its dividend despite these challenges signals a dedication to shareholder returns and financial stability, albeit in the face of profitability hurdles.
• Analysts and investors are likely reevaluating Humana's position in the healthcare sector, weighing the affirmed dividend against the backdrop of evolving regulatory risks and the company's strategic focus on medical cost control and value-based care.
• The broader market sentiment towards healthcare stocks, regulatory concerns, and the company's ability to navigate policy-driven risks are contributing factors to Humana's bearish movement today.

29.03.2026 - HUM Stock was up 5.0%

• Humana's strong bullish movement today is due to the company's better-than-expected first-quarter earnings and revenue performance, despite a slight dip in net income.
• The anticipation of a significant 25% growth in Medicare Advantage membership has also contributed to the positive market sentiment towards Humana.
• Despite concerns about ongoing margin pressure due to rising medical costs, Humana's reaffirmation of its fiscal 2026 adjusted earnings per share and profit recovery strategy for 2027 and 2028 have reassured investors and analysts.
• The company's focus on returning to a 3% Medicare Advantage margin in 2028 as a top priority, even if it means benefit cuts or plan exits, showcases a commitment to long-term profitability and stability, which has likely boosted investor confidence in the stock.

07.03.2026 - HUM Stock was up 5.8%

• Humana's stock surged by 9.8% in premarket trading, outperforming other companies like Valmont Industries and Loews.
• The bullish movement can be attributed to the overall positive sentiment in health insurance stocks, following the federal government's announcement of a 2.48% increase in Medicare payments to insurers for the next year.
• The decision to significantly raise Medicare payments for private health insurers, including Humana, reflects a favorable regulatory environment for the industry, leading to increased investor confidence and driving the stock price higher.
• Investors are reacting positively to the news, as the revised plan means additional revenue for companies like Humana through Medicare Advantage, a key component of their business, ultimately boosting the stock's performance.

28.03.2026 - HUM Stock was up 5.2%

• Humana (HUM) experienced a strong bullish movement today, with shares rising by 3.9%.
• The positive market movement can be attributed to the overall positive sentiment in the health insurance sector, as investors anticipate the company's Q1 earnings report.
• Analysts and investors are showing confidence in Humana's future performance, as indicated by the significant undervaluation of the stock according to GuruFocus' GF Value estimate.
• The upcoming earnings report and expectations for strong revenue growth are likely driving the bullish momentum in Humana's stock price.

30.03.2026 - HUM Stock was up 7.9%

• The bullish movement in Humana's stock is linked to its robust first-quarter earnings performance, surpassing expectations despite a year-over-year profit decrease.
• Investor optimism is fueled by expectations of a substantial 25% growth in Medicare Advantage membership for the year, indicating strong member retention and revenue potential.
• Despite concerns about margin pressure from escalating medical costs surpassing funding, Humana's strategic focus on profit recovery and cost efficiencies is well-received by investors, propelling the stock upwards.
• Humana's commitment to reaching a 3% Medicare Advantage margin by 2028, even if necessitating benefit reductions or plan exits, exhibits a clear strategy for enhancing profitability and long-term stability, bolstering investor confidence in the stock.

21.03.2026 - HUM Stock was up 5.1%

• Despite a Humana director reporting zero common shares, this development had little impact on the stock price.
• The rise in Humana's stock value was likely influenced by a positive market outlook following another healthcare company's strong Q1 2026 performance, which had a ripple effect on Humana and similar firms.
• Approval of key proposals during Humana's annual meeting, including director re-election and stock incentive plan approval, likely boosted investor confidence in the company's future.
• Factors such as disclosed lobbying expenditures on critical healthcare issues, favorable analyst evaluations, and price targets likely contributed to the upward momentum in Humana's stock value.

21.03.2026 - HUM Stock was up 6.8%

• Today, Humana experienced a significant bullish movement, which may be attributed to the outcomes of their annual shareholder meeting. During the meeting, all ten directors were re-elected, the 2026 auditor ratification was approved, and the stock incentive plan was adopted. These decisions indicate strong investor confidence in the company's leadership and strategic direction.
• The rejection of the proposal to tighten oversight on golden parachute arrangements could have also contributed to the positive market sentiment, suggesting support for the company's executive compensation practices.
• The disclosure of lobbying expenses related to key healthcare issues such as Medicare Advantage and Medicaid, coupled with favorable ratings and price targets from Wall Street analysts, likely boosted investor confidence in Humana's future prospects.
• In summary, the combination of favorable shareholder decisions, strategic efforts like the expansion of palliative care services, and positive analyst sentiment may have driven the bullish momentum in Humana's stock today.